- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- F-1/A Registration statement (foreign)
- 3.2 EX-3.2
- 4.1 EX-4.1
- 8.2 EX-8.2
- 10.1 EX-10.1
- 10.14 EX-10.14
- 10.18 EX-10.18
- 10.19 EX-10.19
- 10.20 EX-10.20
- 10.21 EX-10.21
- 10.22 EX-10.22
- 15.1 EX-15.1
- 23.1 EX-23.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
- 99.8 EX-99.8
- 99.9 EX-99.9
- 99.10 EX-99.10
- EX-FILING FEES Ex-filing Fees
- 17 Apr 23 424B4 Prospectus supplement with pricing info
- 3 Apr 23 EFFECT Notice of effectiveness
- 31 Mar 23 FWP Free writing prospectus
- 30 Mar 23 F-1/A Registration statement (foreign) (amended)
- 27 Mar 23 F-1/A Registration statement (foreign) (amended)
- 15 Mar 23 F-1/A Registration statement (foreign) (amended)
- 27 Feb 23 FWP Free writing prospectus
- 21 Feb 23 F-1/A Registration statement (foreign) (amended)
-
31 Jan 23 F-1/A Registration statement (foreign) (amended)
- 18 Nov 22 F-1 Registration statement (foreign)
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation of our report dated September 30, 2022, except Notes 1 and 28, for which the date is January 31, 2023 in Amendment No.1 to the Registration Statement on Form F-1, under the Securities Act of 1933 (File No. 333-268456) with respect to the consolidated statements of financial position of CytoMed Therapeutics Limited and its subsidiaries (the “Company”) as of December 31, 2020 and 2021, and the related consolidated statements of profit or loss and other comprehensive income, changes in equity, and cash flows for each of the years in two-year period ended December 31, 2021, and the related notes included herein.
We also consent to the reference to our firm under the heading “Experts” in the Prospectus.
 | |
| San Mateo, California | WWC, P.C. |
| January 31, 2023 | Certified Public Accountants |
| PCAOB ID: 1171 |
